{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-09",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "69729-070",
      "generic_name": "Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl",
      "labeler_name": "OPMX LLC",
      "brand_name": "Tenalif Children",
      "active_ingredients": [
        {
          "name": "ACETAMINOPHEN",
          "strength": "250 mg/10mL"
        },
        {
          "name": "PHENYLEPHRINE HYDROCHLORIDE",
          "strength": "5 mg/10mL"
        },
        {
          "name": "DEXTROMETHORPHAN HYDROBROMIDE",
          "strength": "13.33 mg/10mL"
        },
        {
          "name": "GUAIFENESIN",
          "strength": "200 mg/10mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "69729-070-06",
          "description": "1 BOTTLE, PLASTIC in 1 CARTON (69729-070-06)  / 177 mL in 1 BOTTLE, PLASTIC",
          "marketing_start_date": "20230918",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "OPMX LLC"
        ],
        "rxcui": [
          "1790651"
        ],
        "spl_set_id": [
          "05cd9513-1a42-e990-e063-6294a90a57df"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0810053180525"
        ],
        "nui": [
          "N0000193956",
          "N0000008867",
          "N0000009560"
        ],
        "pharm_class_epc": [
          "Expectorant [EPC]"
        ],
        "pharm_class_pe": [
          "Decreased Respiratory Secretion Viscosity [PE]",
          "Increased Respiratory Secretions [PE]"
        ],
        "unii": [
          "362O9ITL9D",
          "04JA59TNSJ",
          "9D2RTI9KYH",
          "495W7451VQ"
        ]
      },
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "SYRUP",
      "spl_id": "2860afb9-3da9-5f80-e063-6394a90ab76b",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20230918",
      "product_id": "69729-070_2860afb9-3da9-5f80-e063-6394a90ab76b",
      "application_number": "M012",
      "brand_name_base": "Tenalif Children",
      "pharm_class": [
        "Adrenergic alpha1-Agonists [MoA]",
        "Decreased Respiratory Secretion Viscosity [PE]",
        "Expectorant [EPC]",
        "Increased Respiratory Secretions [PE]",
        "Sigma-1 Agonist [EPC]",
        "Sigma-1 Receptor Agonists [MoA]",
        "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]",
        "Uncompetitive NMDA Receptor Antagonists [MoA]",
        "alpha-1 Adrenergic Agonist [EPC]"
      ]
    }
  ]
}